About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Chicago | 17,800 Studies Near You

Clinical TrialsChicago

Clinical Trials in Chicago

Discover 17,800 clinical trials near Chicago, Illinois. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1221-1240 of 17,800 trials

CompletedCombination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic SyndromesThis phase III trial is studying how well combination chemotherapy works in treating young patients with Down syndrome and acute myeloid leukemia or myelodysplastic syndromes.NCT00369317·Phoenix, Arizona and 96 others

Find Trials by Condition in Chicago

Breast Cancerin Chicago Lung Cancerin Chicago Prostate Cancerin Chicago Colorectal Cancerin Chicago Melanomain Chicago Leukemiain Chicago Lymphomain Chicago Pancreatic Cancerin Chicago Ovarian Cancerin Chicago Brain Cancerin Chicago Diabetes

Data from ClinicalTrials.govTerms

CompletedPhase 3 Study of Dexpramipexole in ALSThe purpose of this study is to determine whether dexpramipexole (150 mg twice daily) is safe and effective in the treatment of Amyotrophic Lateral Sclerosis (ALS).NCT01281189·Phoenix, Arizona and 81 others

RecruitingA Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)A Phase 3 Double-blind, Placebo-controlled Study (Part A) with an Open-label Extension (Part B) Evaluating DT120 Compared to Placebo in Major Depressive Disorder - AscendNCT07592689·Little Rock, Arkansas and 29 others

CompletedA Randomized, Double-Blind, Comparative Study of Azithromycin Versus Clarithromycin in Combination With Ethambutol for the Treatment of Disseminated Mycobacterium Avium Complex (MAC) Infection in AIDs PatientsTo evaluate the efficacy and safety of two different doses of azithromycin in combination with ethambutol for the treatment of patients with Mycobacterium avium complex (MAC)…NCT00002140·Berkeley, California and 23 others

CompletedA Multicenter Phase 2 Study of Ibrutinib in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) With 17p DeletionAn Open-label, Single arm, Multicenter Phase 2 Study of the Bruton's Tyrosine Kinase Inhibitor ibrutinib in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia or…NCT01744691·Phoenix, Arizona and 54 others

Enrolling by invitationWIM Exosuit Wearable Soft Robot for Enhancing Walking ActivityThis study is to develop, test, and optimize a soft hip wearable robot for individuals with stroke, Parkinson's, multiple sclerosis, or older adults with no neurologic deficits.NCT07061691·Chicago, Illinois

CompletedSafety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular RosaceaThe purpose of this study is to assess the safety and efficacy of azelaic acid (AzA) foam, 15% topically applied twice daily for 12 weeks in subjects with papulopustular rosacea…NCT01555463·Birmingham, Alabama and 48 others

CompletedISIS 104838, an Inhibitor of Tumor Necrosis Factor, for Active Rheumatoid ArthritisISIS 104838 is an antisense oligonucleotide drug that reduces the production of a specific protein called tumor necrosis factor (TNF-alpha), a substance that contributes to joint…NCT00048321·Birmingham, Alabama and 30 others

CompletedVeliparib and Temozolomide in Treating Patients With Recurrent GlioblastomaRATIONALE: Veliparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT01026493·La Jolla, California and 16 others

Active not recruitingRegional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast CancerThe purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation…NCT03488693·Fairbanks, Alaska and 484 others

No longer availableExpanded Access Protocol to Provide Patisiran to Patients With Transthyretin-mediated Amyloidosis With CardiomyopathyThe objective of the study is to assess the long-term safety of patisiran in patients with ATTR amyloidosis with cardiomyopathy as assessed by a review of adverse events (AEs).NCT05505838·Phoenix, Arizona and 19 others

Active not recruitingLinezolid for Syphilis Pilot StudyThe study aims to evaluate the efficacy of linezolid for the treatment of syphilis.NCT05548426·Chicago, Illinois and 4 others

Active not recruitingMelanated Group Midwifery Care (MGMC)This study is being conducted to determine if a multi-level intervention for delivering maternity care can improve patient trust and engagement among Black birthing people.NCT05365815·Chicago, Illinois

CompletedA Study of the Effect of XmAb®5871 in Patients With Systemic Lupus ErythematosusThe purpose of this study is to determine the ability of XmAb5871 to maintain Systemic Lupus Erythematosus (SLE) disease activity improvement achieved by a brief course of…NCT02725515·La Jolla, California and 22 others

CompletedSafety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Genotype 1 HCV InfectionThis primary objectives of the study are to evaluate the safety, tolerability, and efficacy of voxilaprevir (VOX) plus sofosbuvir/velpatasvir (SOF/VEL) fixed dose combination…NCT02378935·Los Angeles, California and 33 others

CompletedCombination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Brain Stem GliomaRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003625·Birmingham, Alabama and 73 others

TerminatedEfficacy and Safety of QGE031 (Ligelizumab) in Patients With Peanut AllergyThis was a 52-week, Phase 3 multi-center, randomized, double-blind and placebo-controlled study to assess the safety and clinical efficacy of two dosing regimens of ligelizumab…NCT04984876·Birmingham, Alabama and 54 others

CompletedIndividual Differences in Diabetes Risk: Role of Sleep DisturbancesThe hypothesis for this study is that some individuals may be at much higher risk to develop type 2 diabetes and that the individual diabetes risk will be predicted by the…NCT00989976·Chicago, Illinois

CompletedSofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic HCV InfectionThe primary objectives of this study are to evaluate the efficacy, safety, and tolerability of sofosbuvir/velpatasvir (SOF/VEL) fixed dose combination (FDC) for 12 weeks in adults…NCT02201940·Little Rock, Arkansas and 79 others

CompletedA Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)This randomized, multicenter, double-blind, placebo-controlled, parallel-group study will evaluate the efficacy and safety of lebrikizumab as monotherapy in the absence of…NCT01872689·Birmingham, Alabama and 111 others

PreviousPage 62 of 890Next

in Chicago

Heart Diseasein Chicago